Anavex Life Sciences (AVXL) Shares Outstanding (2010 - 2025)

Anavex Life Sciences' Shares Outstanding history runs 16 years deep, the most recent figure standing at $92.7 million for Q4 2025.

• In Q4 2025, Shares Outstanding rose 9.04% year-over-year to $92.7 million; the TTM figure through Dec 2025 stood at $92.7 million (up 9.04% YoY), while the FY2025 annual figure was $86.7 million, up 2.21% from the prior year.
• Shares Outstanding came in at $92.7 million for Q4 2025 at Anavex Life Sciences, up from $86.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $92.7 million in Q4 2025 to a low of $70.0 million in Q1 2021.
• A 5-year average of $81.1 million and a median of $81.7 million in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding climbed 25.08% in 2021 and advanced 0.73% in 2025, its largest moves.
• Anavex Life Sciences' Shares Outstanding stood at $76.2 million in 2021, then rose by 2.46% to $78.0 million in 2022, then rose by 5.2% to $82.1 million in 2023, then gained by 3.53% to $85.0 million in 2024, then climbed by 9.04% to $92.7 million in 2025.
• According to Business Quant data, Shares Outstanding over the past three periods registered $92.7 million, $86.7 million, and $85.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison